Axa’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

Axa’s Portfolio AMPE Stock Details AMPE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-101	Closed	-$39K	–	1383
2016 Q2	$39K	Buy	+101	New	+$110K	﹤0.01%	1307

Other funds holding AMPE

KCM

Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

NFG

Noven Financial Group Denver, Colorado $123M AUM 5.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BIM

BlackRock Investment Management Wilmington, Delaware $86.4B AUM 16.83% 1-Year Est. Return

Axa's AMPE Position: Q3 2016 in Review

Axa sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q3 2016, closing a stake of 101 shares — an estimated $39K sold.

Axa first reported a position in AMPE in Q2 2016 and held it in 1 quarter. The position peaked at $39K in Q2 2016. 71 funds tracked by Wall St. Rank hold AMPE as of Q3 2016.

Axa reported no remaining Ampio Pharmaceuticals Inc. position as of Q3 2016 after selling out during the quarter.
Axa sold 101 Ampio Pharmaceuticals Inc. shares in Q3 2016, an estimated $39K.
Axa first reported a position in Ampio Pharmaceuticals Inc. in Q2 2016 and held it in 1 quarter.
Axa's Ampio Pharmaceuticals Inc. position peaked at $39K in Q2 2016.
71 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q3 2016.

Based on Axa's 13F filing for Q3 2016, filed 10 Nov 2016.